Valganciclovir Market Growing at 5.65% CAGR Through 2034
The valganciclovir market is witnessing steady growth as the demand for effective antiviral therapies continues to increase worldwide. Valganciclovir is widely used for the prevention and treatment of cytomegalovirus (CMV) infections, particularly among transplant recipients and immunocompromised patients. Growing awareness of viral infection management, expanding organ transplantation...
0 Comments
0 Shares